Collaborating researchers at the University of Iowa and Capital Medical University in Beijing, China, found that a drug used to treat enlarged prostate, terazosin, appears able to slow the progress of Parkinson’s disease.
Researchers have discovered that a natural hypertension medicine blocks an enzyme that may be central to idiopathic Parkinson’s disease.
A neurodegenerative disease characterized by iron accumulation in the brain has been successfully slowed using iron chelation therapy.
Can viruses be created that cross the blood-brain barrier and treat neurological diseases like Parkinson’s? It’s looking more likely that this will be a real possibility.
Accessible designs that make the everyday tasks of those living with Parkinson’s a bit easier.
Treatment of symptoms is certainly lucrative. But there is a desperate need for treatments that slow, stop, or reverse the disease itself.
Out of 2,000 compounds, the screen found a family of new drugs, including an existing drug called UDCA, that allowed the mitochondria to work again.
